Enhanced Antitumor Effects with Intralymphatic Delivery Using Bacillus Calmette-Guerin in Animal Models
- 1 January 1985
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Drug Delivery
- Vol. 2 (2) , 127-132
- https://doi.org/10.1089/cdd.1985.2.127
Abstract
This study compares the effectiveness of various routes of administration of Bacillus Calmette-Guerin (BCG) utilizing the New Zealand white (NZW) rabbit V2 carcinoma model. The routes compared were intratumor, intravenous, scarification, subcutaneous, and intralymphatic. Primary tumor regression, diseasefree interval, and survival were measured. The disease-free interval and survival for the intralymphatic group were significantly longer (p<0.05) than all groups except the scarification group. That group had a prolonged survival as compared with all groups except the intralymphatic group. The intralymphatic route of administration was the most effective method in causing local tumor regression and curtailing metastasis. This study clearly demonstrates that the intralymphatic route requires further mechanistic studies and clinical investigation as a means for delivering biological response modifiers.This publication has 12 references indexed in Scilit:
- Monoclonal Antibodies in the Lymphatics: Selective Delivery to Lymph Node Metastases of a Solid TumorScience, 1983
- Monoclonal Antibodies in the Lymphatics: Toward the Diagnosis and Therapy of Tumor MetastasesScience, 1982
- Immunotherapy of Metastases Enhances Subsequent ChemotherapyScience, 1982
- A phase I study of active specific intralymphatic immunotherapy (ASILI)Cancer, 1978
- Intralymphatic bcg in the treatment of gynecologic malignancies.A phase I studyCancer, 1977
- Intralymphatic administration of BCG in melanoma patientsCancer Immunology, Immunotherapy, 1977
- Studies concerning the regional lymph node in cancerVIII. Effect of two asynchronous tumor foci on lymph node cell cytotoxicityCancer, 1975
- Possible role of uninvolved regional nodes in preventing metastasis from breast cancerCancer, 1969
- THE ROLE OF AFFERENT LYMPHATICS IN THE REJECTION OF SKIN HOMOGRAFTSThe Journal of Experimental Medicine, 1968
- A TRANSPLANTABLE RABBIT CARCINOMA ORIGINATING IN A VIRUS-INDUCED PAPILLOMA AND CONTAINING THE VIRUS IN MASKED OR ALTERED FORMThe Journal of Experimental Medicine, 1940